UA35638C2 - Моногідрат гідрохлориду 1-циклопропіл-7-([s,s]-2,8-діазабіцикло[4.3.0]нон-8-іл)- 6-фтор-1,4-дигідро-8-метокси-4-оксо-3-хінолінкарбонової кислоти та фармацевтична композиція з антибактеріальною активністю - Google Patents

Моногідрат гідрохлориду 1-циклопропіл-7-([s,s]-2,8-діазабіцикло[4.3.0]нон-8-іл)- 6-фтор-1,4-дигідро-8-метокси-4-оксо-3-хінолінкарбонової кислоти та фармацевтична композиція з антибактеріальною активністю

Info

Publication number
UA35638C2
UA35638C2 UA96124628A UA96124628A UA35638C2 UA 35638 C2 UA35638 C2 UA 35638C2 UA 96124628 A UA96124628 A UA 96124628A UA 96124628 A UA96124628 A UA 96124628A UA 35638 C2 UA35638 C2 UA 35638C2
Authority
UA
Ukraine
Prior art keywords
quinolinecarboxylic acid
diazabicyclo
monohydrate
cyclopropyl
dihydro
Prior art date
Application number
UA96124628A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Альфонс Груненберг
Патрік Боше
Патрик Боше
Original Assignee
Баєр Акціенгезельшафт
Байер Акциенгезельшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7779831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA35638(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Баєр Акціенгезельшафт, Байер Акциенгезельшафт filed Critical Баєр Акціенгезельшафт
Publication of UA35638C2 publication Critical patent/UA35638C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
UA96124628A 1995-12-12 1996-12-11 Моногідрат гідрохлориду 1-циклопропіл-7-([s,s]-2,8-діазабіцикло[4.3.0]нон-8-іл)- 6-фтор-1,4-дигідро-8-метокси-4-оксо-3-хінолінкарбонової кислоти та фармацевтична композиція з антибактеріальною активністю UA35638C2 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19546249A DE19546249A1 (de) 1995-12-12 1995-12-12 Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
UA35638C2 true UA35638C2 (uk) 2001-04-16

Family

ID=7779831

Family Applications (1)

Application Number Title Priority Date Filing Date
UA96124628A UA35638C2 (uk) 1995-12-12 1996-12-11 Моногідрат гідрохлориду 1-циклопропіл-7-([s,s]-2,8-діазабіцикло[4.3.0]нон-8-іл)- 6-фтор-1,4-дигідро-8-метокси-4-оксо-3-хінолінкарбонової кислоти та фармацевтична композиція з антибактеріальною активністю

Country Status (42)

Country Link
US (1) US5849752A (show.php)
EP (1) EP0780390B1 (show.php)
JP (1) JP4104687B2 (show.php)
KR (1) KR100525146B1 (show.php)
CN (1) CN1061348C (show.php)
AR (1) AR005009A1 (show.php)
AT (1) ATE221531T1 (show.php)
AU (1) AU708006B2 (show.php)
BG (1) BG62258B1 (show.php)
BR (1) BR9605968A (show.php)
CA (1) CA2192418C (show.php)
CO (1) CO4480105A1 (show.php)
CU (1) CU22774A3 (show.php)
CZ (1) CZ288657B6 (show.php)
DE (2) DE19546249A1 (show.php)
DK (1) DK0780390T3 (show.php)
EE (1) EE03474B1 (show.php)
ES (1) ES2179910T3 (show.php)
HR (1) HRP960558B1 (show.php)
HU (1) HU226521B1 (show.php)
ID (1) ID22625A (show.php)
IL (1) IL119795A (show.php)
IN (1) IN185805B (show.php)
MA (1) MA24342A1 (show.php)
MY (1) MY117492A (show.php)
NL (1) NL300109I1 (show.php)
NO (1) NO306725B1 (show.php)
NZ (1) NZ299905A (show.php)
PL (1) PL184885B1 (show.php)
PT (1) PT780390E (show.php)
RO (1) RO119782B1 (show.php)
RU (1) RU2162468C2 (show.php)
SA (1) SA96170492B1 (show.php)
SG (1) SG47201A1 (show.php)
SI (1) SI0780390T1 (show.php)
SK (1) SK282805B6 (show.php)
SV (1) SV1996000109A (show.php)
TR (1) TR199600970A2 (show.php)
TW (1) TW411340B (show.php)
UA (1) UA35638C2 (show.php)
YU (1) YU49485B (show.php)
ZA (1) ZA9610405B (show.php)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9812553B1 (pt) * 1997-09-25 2010-06-01 formulação medicamentosa em pélete de difusão controlada e em um sistema matriz.
DE19751948A1 (de) 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
BRPI9915208B8 (pt) * 1998-11-10 2021-07-06 Bayer Ag preparados farmacêutico e de comprimido para a aplicação oral compreendendo moxifloxacina e seu processo de preparação.
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854356A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908449A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
US20060252789A1 (en) * 2002-10-31 2006-11-09 Sujay Biswas Amorphous moxifloxacin hydrochloride
EP2113505A1 (en) 2003-04-09 2009-11-04 Dr. Reddy's Laboratories, Ltd. A crystalline form III of anhydrous moxifloxacin hydrochloride and processes for the preparation thereof
US20060264635A1 (en) * 2003-08-05 2006-11-23 Chava Satyanarayana Process for the preparation of moxifloxacin hydrochloride
ITMI20032259A1 (it) 2003-11-20 2005-05-21 Chemi Spa Nuovo polimorfo dell'acido 1-ciclopropil-7-(s,s-2,8-diazabciclo-4.3.0-non-8-il)-6-fluoro-1,4-diidro-8-metossi-4-oxo-chinolin carbossilico cloridrato e metodi per la sua preparazione
WO2005054240A1 (en) * 2003-11-20 2005-06-16 Chemi Spa Polymorphs of 1-cyclopropyl-7-([s,s]-2,8-diazadicyclo[4.3.0]non-8-yl)-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylic acid hydrochloride and methods for the preparation thereof
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
DE102004015981A1 (de) * 2004-04-01 2005-10-20 Bayer Healthcare Ag Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE102004063347A1 (de) * 2004-12-23 2006-07-13 Stada Arzneimittel Ag Gebrauchsfertige Gemcitabinlösungen und Gemcitabinlösungskonzentrate
WO2007033515A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation orale contenant de la moxifloxacine et son procédé de préparation
GB0612422D0 (en) * 2006-06-23 2006-08-02 Generics Uk Ltd Novel hydrate form
EP2436381A1 (en) 2006-06-27 2012-04-04 Sandoz AG Crystallization of hydrohalides of pharmaceutical compounds
ES2303768B1 (es) * 2006-09-08 2009-06-05 Quimica Sintetica, S.A. Nueva forma cristalina de moxifloxacino clorhidrato.
KR20150048920A (ko) * 2006-11-13 2015-05-07 씨아이피엘에이 엘티디. 목시플록사신 염산염의 합성방법
EP1992626A1 (en) * 2007-05-10 2008-11-19 Sandoz AG Process for the preparation of moxifloxacin hydrochloride
EP2083010A1 (en) * 2008-01-08 2009-07-29 Chemo Ibérica, S.A. Polymorphic Forms of Moxifloxacin hydrochloride and processes for preparation thereof
EP2154137A1 (en) 2008-08-04 2010-02-17 Chemo Ibérica, S.A. Crystalline form of moxifloxacin base
PL2349220T3 (pl) * 2008-10-09 2012-12-31 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Zastosowanie rozpuszczalników organicznych w granulacji na mokro moksyfloksacyny
WO2010052726A1 (en) * 2008-11-06 2010-05-14 Hetero Research Foundation Novel polymorph of moxifloxacin hydrochloride
EP2735307A1 (de) 2008-12-08 2014-05-28 Ratiopharm GmbH Kompaktiertes Moxifloxacin
BRPI1010981A2 (pt) 2009-05-15 2018-12-04 Redx Pharma Ltd "derivados de fármaco redox"
WO2011121596A2 (en) * 2010-04-01 2011-10-06 Neuland Laboratories Ltd. Crystal modification of moxifloxacin hydrochloride
BRPI1106900A2 (pt) 2011-12-26 2013-11-05 Ems Sa Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção
FR2992218B1 (fr) 2012-06-22 2015-01-23 Rivopharm Sa Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
CN102924449B (zh) * 2012-10-30 2015-08-12 重庆福安药业集团庆余堂制药有限公司 盐酸莫西沙星h晶型及其制备方法和药物组合物
WO2014087292A1 (en) 2012-12-04 2014-06-12 Mankind Research Centre An improved process for the preparation of moxifloxacin hydrochloride
RU2561037C2 (ru) * 2013-02-07 2015-08-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Антибактериальная фармацевтическая композиция и способ ее получения
WO2014152332A1 (en) 2013-03-15 2014-09-25 Melinta Therapeutics, Inc. Methods of treating infections in overweight and obese patients using antibiotics

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601567A1 (de) * 1986-01-21 1987-07-23 Bayer Ag 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate
DK164287A (da) * 1986-03-31 1987-10-01 Sankyo Co Quinolin-3-carboxylsyrederivater og fremgangsmaade til fremstilling deraf og deres anvendelse
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
RO108347B1 (ro) * 1989-10-30 1994-04-28 Bellon Labor Sa Roger DERIVATI DE BENZO-(b)-NAFTIRIDIN-1,8 SI PROCEDEU DE PREPARARE A ACESTORA
TW209865B (show.php) 1992-01-10 1993-07-21 Bayer Ag
EP0629621B1 (en) * 1992-01-31 2001-10-24 Chugai Seiyaku Kabushiki Kaisha Crystal of quinolonecarboxylic acid derivative hydrate
DE4234078A1 (de) * 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
CA2112165C (en) * 1992-12-25 2003-04-08 Makoto Takemura Bicyclic amine derivatives
ZA946853B (en) * 1993-09-10 1995-04-24 Daiichi Seiyaku Co Crystals of antimicrobial compound.
EP0676199B1 (en) * 1994-04-07 1998-09-02 Pfizer Inc. Use of trovafloxacin or derivatives thereof for the manufacture of a medicament for the treatment of H. pylori infections

Also Published As

Publication number Publication date
SK282805B6 (sk) 2002-12-03
TR199600970A2 (tr) 1997-06-21
MY117492A (en) 2004-07-31
CA2192418A1 (en) 1997-06-13
ID22625A (id) 1999-12-02
CU22774A3 (es) 2002-07-24
MA24342A1 (fr) 1998-07-01
EP0780390B1 (de) 2002-07-31
JP4104687B2 (ja) 2008-06-18
MX9606325A (es) 1997-10-31
HUP9603428A2 (en) 1997-08-28
NL300109I1 (nl) 2003-02-03
CZ288657B6 (cs) 2001-08-15
DE59609501D1 (de) 2002-09-05
RU2162468C2 (ru) 2001-01-27
AU708006B2 (en) 1999-07-29
IL119795A (en) 1998-12-27
BR9605968A (pt) 1998-08-18
HRP960558A2 (en) 1998-02-28
ATE221531T1 (de) 2002-08-15
YU65096A (sh) 1998-12-23
AR005009A1 (es) 1999-04-07
KR100525146B1 (ko) 2006-01-27
CO4480105A1 (es) 1997-07-09
PL184885B1 (pl) 2003-01-31
PT780390E (pt) 2002-11-29
EE9600201A (et) 1997-06-16
EE03474B1 (et) 2001-08-15
TW411340B (en) 2000-11-11
EP0780390A1 (de) 1997-06-25
SV1996000109A (es) 1997-10-23
HU9603428D0 (en) 1997-01-28
HUP9603428A3 (en) 1997-10-28
JPH09169757A (ja) 1997-06-30
AU7421696A (en) 1997-06-19
CA2192418C (en) 2001-06-12
SI0780390T1 (en) 2002-10-31
BG101043A (en) 1998-04-30
ES2179910T3 (es) 2003-02-01
NZ299905A (en) 1998-09-24
NO965298D0 (no) 1996-12-11
BG62258B1 (bg) 1999-06-30
RO119782B1 (ro) 2005-03-30
IL119795A0 (en) 1997-03-18
SA96170492B1 (ar) 2006-05-23
NO306725B1 (no) 1999-12-13
ZA9610405B (en) 1997-06-23
SG47201A1 (en) 1998-03-20
PL317415A1 (en) 1997-06-23
US5849752A (en) 1998-12-15
HU226521B1 (en) 2009-03-30
SK159196A3 (en) 1997-10-08
NO965298L (no) 1997-06-13
CN1061348C (zh) 2001-01-31
CZ364696A3 (en) 1997-07-16
YU49485B (sh) 2006-08-17
DE19546249A1 (de) 1997-06-19
HRP960558B1 (en) 2002-04-30
IN185805B (show.php) 2001-05-05
CN1160052A (zh) 1997-09-24
DK0780390T3 (da) 2002-11-11
KR970042550A (ko) 1997-07-24

Similar Documents

Publication Publication Date Title
CA2341690A1 (en) Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents
CA2358998A1 (en) Substituted bicyclic derivatives useful as anticancer agents
AU4925199A (en) Quinolin-2-one derivatives useful as anticancer agents
CA2182981A1 (en) Sublingual or buccal pharmaceutical composition
GB9914486D0 (en) Medicaments
MY122779A (en) Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition.
RU96123410A (ru) Моногидрат гидрохлорида 1-циклопропил-7-([s,s]-2,8-диазабицикло[4.3.0] нон-8-ил)- 6-фтор-1,4-дигидро-8-метокси-4-оксо-3-хинолинкарбоновой кислоты и фармацевтическая композиция с антибактериальной активностью
BG105860A (en) Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
IL113581A0 (en) Propiophenone derivatives their preparation and pharmaceutical compositions containing them and their use
CA2392973A1 (en) Benzoimidazole derivatives useful as antiproliferative agents
CA2413424A1 (en) Substituted bicyclic derivatives for the treatment of abnormal cell growth
YU11501A (sh) Derivati 4,4,-biarilpiperidina sa aktivnošću na receptor opijata
TW200500344A (en) Novel compounds
TWI256951B (en) Thiazolyl amide derivatives
MY117492A (en) New crystal modification of cdch, a process for its preparation and pharmaceutical formulations comprising this modification
CA2258548A1 (en) Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
BG105810A (en) Camptothecin derivatives having antitumor activity
BR9805734A (pt) Derivados de imidazolin-4-ona úteis como agentes anticancerìgenos.
EP0915094A4 (en) MORPHINANE DERIVATIVES AND MEDICAL USE THEREOF
CA2105923A1 (en) 7-isoindolinyl-quinolone derivatives and 7-isoindolinyl-naphthyridone derivatives
CA2107223A1 (en) Crystalline tiagabine hydrochloride monohydrate, its preparation and use
PH31375A (en) Antimicrobial quinolonyl lactam esters.
CA2109435A1 (en) Compositions of N-(Phosphonoacetyl)-L-Aspartic Acid and Methods of Their Use as Broad Spectrum Antivirals
CA2380455A1 (en) 9a-azalides with antibacterial activity
IL125628A0 (en) Benzo[c] quinolizine derivatives their preparation and use as 5alpha-reductase inhibitors